Fatemeh Nasiri-Amiri1, Fahimeh Ramezani Tehrani2, Masoumeh Simbar3, Ali Montazeri4, Reza Ali Mohammadpour5. 1. Department of Midwifery, Babol University of Medical Sciences, Babol, Iran. 2. Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, 24 Parvaneh, Yaman Street, Velenjak, P.O. Box 19395-4763, Tehran, 1985717413, Iran. ramezani@endocrine.ac.ir. 3. Department of Midwifery and Reproductive Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 4. Mental Health Research Group, Health Metrics Research Centre, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran. 5. Department of Biostatistics, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract
PURPOSE: The determinants of the health-related quality of life of women with polycystic ovary syndrome are not fully understood. The aim of this study was to develop a comprehensive instrument to assess the health-related quality of life of Iranian women with PCOS and to assess its psychometric properties. METHODS: We used a mixed-method, sequential, exploratory design including both qualitative [in-depth interview to define the components of health-related quality of life questionnaire (PCOSQ)] and quantitative approaches (to assess the psychometric properties of PCOSQ). RESULTS: A preliminary questionnaire was developed including 147 items which emerged from the qualitative phase of the study. Considering the optimum cutoff points for content validity ratio (CVR), content validity index (CVI), and impact score, items of the preliminary questionnaire were reduced from 147 to 88 items. Finally, by excluding highly correlated items using the exploratory factor analysis, a 50-item questionnaire was obtained. The Kaiser criteria (eigenvalues >1) and Scree plot tests demonstrated that six factors were optimum with an estimated 47.3 % of variance. Assessment of the psychometric properties of the questionnaire demonstrated a mean CVI = 0.92, CVR = 0.91, Cronbach's alpha for whole questionnaire = 0.88 (0.61-0.88 for subscales), Spearman's correlation coefficients of test-retest = 0.75, and the intra-class correlation coefficient for the PCOS questionnaire subscales ranging from 0.57 to 0.88. Eventually the final questionnaire included 50 items in six domains, 'psychosocial and emotional,' 'fertility,' 'sexual function,' 'obesity and menstrual disorders,' 'hirsutism,' and 'coping' and rated on a 5-point Likert scale. CONCLUSION: The PCOSQ-50 is a valid and reliable instrument for the assessment of quality of life of women with PCOS, capable of assessing some obscure aspects overlooked by previous HRQL questionnaires.
PURPOSE: The determinants of the health-related quality of life of women with polycystic ovary syndrome are not fully understood. The aim of this study was to develop a comprehensive instrument to assess the health-related quality of life of Iranian women with PCOS and to assess its psychometric properties. METHODS: We used a mixed-method, sequential, exploratory design including both qualitative [in-depth interview to define the components of health-related quality of life questionnaire (PCOSQ)] and quantitative approaches (to assess the psychometric properties of PCOSQ). RESULTS: A preliminary questionnaire was developed including 147 items which emerged from the qualitative phase of the study. Considering the optimum cutoff points for content validity ratio (CVR), content validity index (CVI), and impact score, items of the preliminary questionnaire were reduced from 147 to 88 items. Finally, by excluding highly correlated items using the exploratory factor analysis, a 50-item questionnaire was obtained. The Kaiser criteria (eigenvalues >1) and Scree plot tests demonstrated that six factors were optimum with an estimated 47.3 % of variance. Assessment of the psychometric properties of the questionnaire demonstrated a mean CVI = 0.92, CVR = 0.91, Cronbach's alpha for whole questionnaire = 0.88 (0.61-0.88 for subscales), Spearman's correlation coefficients of test-retest = 0.75, and the intra-class correlation coefficient for the PCOS questionnaire subscales ranging from 0.57 to 0.88. Eventually the final questionnaire included 50 items in six domains, 'psychosocial and emotional,' 'fertility,' 'sexual function,' 'obesity and menstrual disorders,' 'hirsutism,' and 'coping' and rated on a 5-point Likert scale. CONCLUSION: The PCOSQ-50 is a valid and reliable instrument for the assessment of quality of life of women with PCOS, capable of assessing some obscure aspects overlooked by previous HRQL questionnaires.
Entities:
Keywords:
Content analysis; Development; Polycystic ovary syndrome; Psychometric; Quality of life
Authors: K Esposito; M Ciotola; F Giugliano; C Bisogni; B Schisano; R Autorino; L Cobellis; M De Sio; N Colacurci; D Giugliano Journal: Int J Impot Res Date: 2007-02-08 Impact factor: 2.896
Authors: Dale W Stovall; Jessica L Scriver; Anita H Clayton; Christopher D Williams; Lisa M Pastore Journal: J Sex Med Date: 2011-11-14 Impact factor: 3.802
Authors: G L Jones; K Benes; T L Clark; R Denham; M G Holder; T J Haynes; N C Mulgrew; K E Shepherd; V H Wilkinson; M Singh; A Balen; H Lashen; W L Ledger Journal: Hum Reprod Date: 2004-02 Impact factor: 6.918
Authors: Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart Journal: Fertil Steril Date: 2011-12-06 Impact factor: 7.329
Authors: Mona L Martin; Katarina Halling; Daniel Eek; Meaghan Krohe; Jean Paty Journal: Health Qual Life Outcomes Date: 2017-08-18 Impact factor: 3.186
Authors: David C Buitenweg; Ilja L Bongers; Dike van de Mheen; Hans A M van Oers; Chijs Van Nieuwenhuizen Journal: Int J Methods Psychiatr Res Date: 2018-05-25 Impact factor: 4.035
Authors: Małgorzata Kałużna; Agnieszka Nomejko; Aleksandra Słowińska; Katarzyna Wachowiak-Ochmańska; Katarzyna Pikosz; Katarzyna Ziemnicka; Marek Ruchała Journal: Endocr Connect Date: 2021-08-30 Impact factor: 3.335